Clinical relevance of IGFBP7 expression has also been confirmed by its identification as a negative prognostic indicator associated with poorer leukemia-free survival rates in patients with non-BCR-ABL1+ B-ALL [127]. Here, IGFBP7 is linked to acute lymphoblastic leukemia.